194 related articles for article (PubMed ID: 28948197)
1. Sequential treatment with zoledronic acid followed by teriparatide or vice versa increases bone mineral density and bone strength in ovariectomized rats.
Shimizu T; Tanaka T; Kobayashi T; Kudo I; Nakatsugawa M; Takakura A; Takao-Kawabata R; Ishizuya T
Bone Rep; 2017 Dec; 7():70-82. PubMed ID: 28948197
[TBL] [Abstract][Full Text] [Related]
2. Raloxifene and teriparatide (hPTH 1-34) have complementary effects on the osteopenic skeleton of ovariectomized rats.
Ma YL; Bryant HU; Zeng Q; Schmidt A; Jee WS; Sato M
J Bone Miner Metab; 2005; 23 Suppl():62-8. PubMed ID: 15984416
[TBL] [Abstract][Full Text] [Related]
3. Effects of combined teriparatide and zoledronic acid on posterior lumbar vertebral fusion in an aged ovariectomized rat model of osteopenia.
Yishake M; Yasen M; Jiang L; Liu W; Xing R; Chen Q; Lin H; Dong J
J Orthop Res; 2018 Mar; 36(3):937-944. PubMed ID: 28796280
[TBL] [Abstract][Full Text] [Related]
4. Effect of Sequential Treatment with Bisphosphonates After Teriparatide in Ovariectomized Rats: A Direct Comparison Between Risedronate and Alendronate.
Yano T; Yamada M; Inoue D
Calcif Tissue Int; 2017 Jul; 101(1):102-110. PubMed ID: 28337514
[TBL] [Abstract][Full Text] [Related]
5. The Effect of Daily Teriparatide versus One-Time Annually Zoledronic Acid Administration After Transforaminal Lumbar Interbody Fusion in Osteoporotic Patients.
Wang Z; Zhuang C; Chen W; Li Z; Li J; Lin H; Dong J
Clin Interv Aging; 2021; 16():1789-1799. PubMed ID: 34934310
[TBL] [Abstract][Full Text] [Related]
6. Zoledronic acid sequential to teriparatide may promote greater inhibition of bone resorption than zoledronic acid alone.
Giveon S; Zacay G; Vered I; Foldes AJ; Tripto-Shkolnik L
Ther Adv Endocrinol Metab; 2023; 14():20420188231213639. PubMed ID: 38028331
[TBL] [Abstract][Full Text] [Related]
7. Differential Effects of Teriparatide and Zoledronic Acid on Bone Mineralization Density Distribution at 6 and 24 Months in the SHOTZ Study.
Dempster DW; Roschger P; Misof BM; Zhou H; Paschalis EP; Alam J; Ruff VA; Klaushofer K; Taylor KA
J Bone Miner Res; 2016 Aug; 31(8):1527-35. PubMed ID: 26931279
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of switching from teriparatide to zoledronic acid or denosumab on bone mineral density and biochemical markers of bone turnover in older patients with severe osteoporosis: a real-life study.
Dito G; Lugaresi M; Degradi C; Guabello G; Longhi M; Corbetta S
Endocrine; 2023 Oct; 82(1):181-189. PubMed ID: 37402061
[TBL] [Abstract][Full Text] [Related]
9. Teriparatide [rhPTH (1-34)], but not strontium ranelate, demonstrated bone anabolic efficacy in mature, osteopenic, ovariectomized rats.
Ma YL; Zeng QQ; Porras LL; Harvey A; Moore TL; Shelbourn TL; Dalsky GP; Wronski TJ; Aguirre JI; Bryant HU; Sato M
Endocrinology; 2011 May; 152(5):1767-78. PubMed ID: 21343258
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the effects of switching oral bisphosphonates to denosumab or daily teriparatide in patients with rheumatoid arthritis.
Ebina K; Hirao M; Hashimoto J; Hagihara K; Kashii M; Kitaguchi K; Matsuoka H; Iwahashi T; Chijimatsu R; Yoshikawa H
J Bone Miner Metab; 2018 Jul; 36(4):478-487. PubMed ID: 28766140
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal Effects of Teriparatide or Zoledronic Acid on Bone Modeling- and Remodeling-Based Formation in the SHOTZ Study.
Dempster DW; Zhou H; Ruff VA; Melby TE; Alam J; Taylor KA
J Bone Miner Res; 2018 Apr; 33(4):627-633. PubMed ID: 29194749
[TBL] [Abstract][Full Text] [Related]
12. A Longitudinal Study of Skeletal Histomorphometry at 6 and 24 Months Across Four Bone Envelopes in Postmenopausal Women With Osteoporosis Receiving Teriparatide or Zoledronic Acid in the SHOTZ Trial.
Dempster DW; Zhou H; Recker RR; Brown JP; Bolognese MA; Recknor CP; Kendler DL; Lewiecki EM; Hanley DA; Rao SD; Miller PD; Woodson GC; Lindsay R; Binkley N; Alam J; Ruff VA; Gallagher ER; Taylor KA
J Bone Miner Res; 2016 Jul; 31(7):1429-39. PubMed ID: 26841258
[TBL] [Abstract][Full Text] [Related]
13. Teriparatide and exercise improve bone, skeletal muscle, and fat parameters in ovariectomized and tail-suspended rats.
Sato C; Miyakoshi N; Kasukawa Y; Nozaka K; Tsuchie H; Nagahata I; Yuasa Y; Abe K; Saito H; Shoji R; Shimada Y
J Bone Miner Metab; 2021 May; 39(3):385-395. PubMed ID: 33392725
[TBL] [Abstract][Full Text] [Related]
14. Treatment Sequence Matters: Anabolic and Antiresorptive Therapy for Osteoporosis.
Cosman F; Nieves JW; Dempster DW
J Bone Miner Res; 2017 Feb; 32(2):198-202. PubMed ID: 27925287
[TBL] [Abstract][Full Text] [Related]
15. Effect of strontium ranelate on lumbar spine bone mineral density in women with established osteoporosis previously treated with teriparatide.
Anastasilakis AD; Polyzos SA; Avramidis A; Papatheodorou A; Terpos E
Horm Metab Res; 2009 Jul; 41(7):559-62. PubMed ID: 19204890
[TBL] [Abstract][Full Text] [Related]
16. Effects of Teriparatide and Sequential Minodronate on Lumbar Spine Bone Mineral Density and Microarchitecture in Osteoporosis.
Miyaoka D; Imanishi Y; Ohara M; Hayashi N; Nagata Y; Yamada S; Mori K; Emoto M; Inaba M
Calcif Tissue Int; 2017 Oct; 101(4):396-403. PubMed ID: 28589205
[TBL] [Abstract][Full Text] [Related]
17. Impact of vitamin C on teriparatide treatment in the improvement of bone mineral density, strength, and quality in vitamin C-deficient rats.
Miyakoshi N; Fujii M; Kasukawa Y; Shimada Y
J Bone Miner Metab; 2019 May; 37(3):411-418. PubMed ID: 30014298
[TBL] [Abstract][Full Text] [Related]
18. The impact of switching once-weekly teriparatide to denosumab in osteoporosis patients.
Miyagi M; Fujimaki H; Naruse K; Suto K; Inoue G; Nakazawa T; Imura T; Saito W; Uchida K; Shirasawa E; Takahira N; Takaso M
J Orthop Sci; 2019 Jan; 24(1):153-158. PubMed ID: 30146385
[TBL] [Abstract][Full Text] [Related]
19. Loss of vertebral bone and mechanical strength in estrogen-deficient rats is prevented by long-term administration of zoledronic acid.
Glatt M; Pataki A; Evans GP; Hornby SB; Green JR
Osteoporos Int; 2004 Sep; 15(9):707-15. PubMed ID: 15024556
[TBL] [Abstract][Full Text] [Related]
20. Changes in bone mineral density and bone turnover markers during treatment with teriparatide in pregnancy- and lactation-associated osteoporosis.
Hong N; Kim JE; Lee SJ; Kim SH; Rhee Y
Clin Endocrinol (Oxf); 2018 May; 88(5):652-658. PubMed ID: 29389010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
